Diego Braguglia

Managing Partner

Industry Team Healthcare

«This is not uninteresting.»
Diego Braguglia

Biography

Diego has more than two decades of venture capital experience and has developed a solid experience in creating, growing and exiting ventures in therapeutics and medical devices. He served as chairman and non-executive director in Endoart (acquired by Allergan), Endosense (acquired by St Jude), Picodrill (acquired by Asahi), Neocutis (acquired by Merz), Amal (acquired by Boehringer Ingelheim), Sequana (IPO on Euronext) and board observer to Genkyotex (IPO on Euronext).

Before entering the VC industry, Diego served as manager in several medical device and pharmaceutical companies.

Diego holds an M.Sc. in Microbiology from the Biocenter of the University of Basel and a PhD in Molecular and Cellular Biology from the Swiss Institute for Experimental Cancer Research (ISREC) in Lausanne.

Portfolio Companies

Covalys

Protein tags for labeling and purification

PicoDrill

Technology to drill holes and cut glass - exited

Xigen

Develop JNK inhibitors as treatment - exited

Genkyotex

Small molecule NOX inhibitors - exited

Endosense

Catheter ablation treatments - exited

EndoArt

Implantable batterie-less medical devices - exited

Amal

Develop oncology vaccine platform KISIMA - exited

NeoGyn

Creams for treatment of vulvar issues - exited

Neocutis

Cosmeceuticals products for skin repair - exited